Noriyuki Azuma

Title: Noriyuki Azuma: Innovator in Retinal Ganglion Cell Preparation

Introduction

Noriyuki Azuma is a prominent inventor based in Tokyo, Japan. He has made significant contributions to the field of stem cell research, particularly in the preparation of retinal ganglion cells. With a total of two patents to his name, Azuma's work is paving the way for advancements in clinical applications.

Latest Patents

Azuma's latest patents focus on a method for the preparation of retinal ganglion cells. The objective of this invention is to provide a method for inducing pluripotent stem cells to differentiate into clinically applicable retinal ganglion cells. The method involves several steps: first, inducing pluripotent stem cells to differentiate into retinal progenitor cells via floating culture. Next, the retinal progenitor cells are induced to differentiate into retinal ganglion cells, also through floating culture. Finally, the axons of the retinal ganglion cells are allowed to elongate via adhesion culture.

Career Highlights

Throughout his career, Noriyuki Azuma has worked with notable organizations such as the National Center for Child Health and Development and Senju Pharmaceutical Co., Ltd. His experience in these institutions has contributed to his expertise in stem cell research and innovation.

Collaborations

Some of Azuma's coworkers include Taku Tanaka and Tadashi Yokoi. Their collaboration has likely enhanced the research and development of methods related to retinal ganglion cells.

Conclusion

Noriyuki Azuma's innovative work in the preparation of retinal ganglion cells represents a significant advancement in the field of stem cell research. His contributions are expected to have a lasting impact on clinical applications in the future.